Paratek Pharmaceuticals to Report First Quarter 2016 Financial Results on May 3, 2016
April 25, 2016 10:13 ET
|
Paratek Pharmaceuticals
BOSTON, April 25, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based...
Paratek Presents Data from Omadacycline Clinical Development Program at ECCMID
April 11, 2016 07:30 ET
|
Paratek Pharmaceuticals
Pooled analysis from Phase 2 and truncated Phase 3 studies demonstrates comparable safety and efficacy profiles for omadacycline compared with linezolid Single dose randomized trial...
Paratek Presents Pre-Clinical Data on the Effects of Omadacycline on Clostridium Difficile
April 11, 2016 07:30 ET
|
Paratek Pharmaceuticals
AMSTERDAM, Netherlands, April 11, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today presented data from two pre-clinical studies evaluating the impact of omadacycline on...
Paratek Announces Completion of Enrollment for Omadacycline Phase 3 Skin Study
April 04, 2016 07:00 ET
|
Paratek Pharmaceuticals
BOSTON, April 04, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that it has completed enrollment in the pivotal Phase 3 clinical study evaluating...
Paratek to Present Clinical Findings at ECCMID 2016
March 29, 2016 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, March 29, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that data from its omadacycline microbiology and clinical program will be presented at the...
Kris Peterson to Join Paratek Board of Directors
March 03, 2016 09:12 ET
|
Paratek Pharmaceuticals
BOSTON, March 03, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that Kris Peterson has been elected to the company’s board of directors. Ms. Peterson has...
Paratek Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
February 23, 2016 07:00 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based...
Paratek Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
February 16, 2016 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that President and Chief Medical Officer, Evan Loh, MD, will participate in two upcoming...
Paratek Pharmaceuticals to Report Fourth Quarter 2015 Financial Results on February 23, 2016
February 16, 2016 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based...
Paratek Pharmaceuticals, Inc. Announces Participation in LEERINK Partners 5th Annual Global Healthcare Conference
January 28, 2016 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) today announced that its President and Chief Medical Officer, Evan Loh, M.D., will participate in the...